i********r
发帖数: 139 | 1 CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 18, 2020-- Moderna, Inc. (Nasdaq:
MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA
) therapeutics and vaccines to create a new generation of transformative
medicines for patients, today announced the pricing of an underwritten
public offering of 17,600,000 shares of common stock at a public offering
price of $76.00 per share, before underwriting discounts and commissions. In
addition, Moderna has granted the underwriters a 30-day option to purchase
up to an additional 2,640,000 shares of common stock at the public offering
price, less underwriting discounts and commissions. All shares of common
stock are being offered by Moderna. Gross proceeds from the offering will be
approximately $1.34 billion. The offering is expected to close on or about
May 21, 2020, subject to the satisfaction of customary closing conditions. | i********r
发帖数: 139 | |
|
